437 related articles for article (PubMed ID: 9649509)
1. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.
Ronco LV; Karpova AY; Vidal M; Howley PM
Genes Dev; 1998 Jul; 12(13):2061-72. PubMed ID: 9649509
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes.
Barnes BJ; Moore PA; Pitha PM
J Biol Chem; 2001 Jun; 276(26):23382-90. PubMed ID: 11303025
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains.
Lin R; Mamane Y; Hiscott J
Mol Cell Biol; 1999 Apr; 19(4):2465-74. PubMed ID: 10082512
[TBL] [Abstract][Full Text] [Related]
4. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
5. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
Poirson J; Suarez IP; Straub ML; Cousido-Siah A; Peixoto P; Hervouet E; Foster A; Mitschler A; Mukobo N; Chebaro Y; Garcin D; Recberlik S; Gaiddon C; Altschuh D; Nominé Y; Podjarny A; Trave G; Masson M
J Virol; 2022 May; 96(10):e0187521. PubMed ID: 35475668
[TBL] [Abstract][Full Text] [Related]
6. IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer.
Rho SB; Lee SH; Byun HJ; Kim BR; Lee CH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076322
[TBL] [Abstract][Full Text] [Related]
7. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.
Wathelet MG; Lin CH; Parekh BS; Ronco LV; Howley PM; Maniatis T
Mol Cell; 1998 Mar; 1(4):507-18. PubMed ID: 9660935
[TBL] [Abstract][Full Text] [Related]
8. Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling.
He B; Paterson RG; Stock N; Durbin JE; Durbin RK; Goodbourn S; Randall RE; Lamb RA
Virology; 2002 Nov; 303(1):15-32. PubMed ID: 12482655
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
10. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.
Liu X; Yuan H; Fu B; Disbrow GL; Apolinario T; Tomaic V; Kelley ML; Baker CC; Huibregtse J; Schlegel R
J Biol Chem; 2005 Mar; 280(11):10807-16. PubMed ID: 15655249
[TBL] [Abstract][Full Text] [Related]
11. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.
Lin R; Heylbroeck C; Pitha PM; Hiscott J
Mol Cell Biol; 1998 May; 18(5):2986-96. PubMed ID: 9566918
[TBL] [Abstract][Full Text] [Related]
12. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
13. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.
Talon J; Horvath CM; Polley R; Basler CF; Muster T; Palese P; García-Sastre A
J Virol; 2000 Sep; 74(17):7989-96. PubMed ID: 10933707
[TBL] [Abstract][Full Text] [Related]
14. Regulation of type I interferon gene expression by interferon regulatory factor-3.
Schafer SL; Lin R; Moore PA; Hiscott J; Pitha PM
J Biol Chem; 1998 Jan; 273(5):2714-20. PubMed ID: 9446577
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-beta gene expression.
Lin R; Mustafa A; Nguyen H; Gewert D; Hiscott J
J Biol Chem; 1994 Jul; 269(26):17542-9. PubMed ID: 8021262
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
17. A truncated form of the IRF-2 transcription factor has the properties of a postinduction repressor of interferon-beta gene expression.
Whiteside ST; King P; Goodbourn S
J Biol Chem; 1994 Oct; 269(43):27059-65. PubMed ID: 7929448
[TBL] [Abstract][Full Text] [Related]
18. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death.
Seo T; Lee D; Shim YS; Angell JE; Chidambaram NV; Kalvakolanu DV; Choe J
J Virol; 2002 Sep; 76(17):8797-807. PubMed ID: 12163600
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites.
Kuo TC; Calame KL
J Immunol; 2004 Nov; 173(9):5556-63. PubMed ID: 15494505
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
Nguyen H; Mustafa A; Hiscott J; Lin R
Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
